Wenjie Xu

Wenjie Xu is an accomplished professional with extensive experience in clinical biomarkers and companion diagnostics development, currently serving as Senior Director, Clinical Biomarkers and CDx Development at BeiGene. Xu has previously held significant roles including Global Precision Medicine Lead in Oncology at AstraZeneca and Principal Scientist in Translational Sciences at NanoString Technologies, Inc. Prior experience includes positions as Senior Research Scientist at Carnegie Mellon University and Senior Research Fellow at Sanford Burnham Prebys Medical Discovery Institute. Educational credentials include a PhD in ICMBS from Columbia University and an MS in Molecular Genetics from Miami University.